Long-term Survival Data from Longeveron's ELPIS 1 Trial : vi

Extended Follow Up Data Show Continued, Transplant Free Survival of All Patients Results Support Continued Investigation of Lomecel-BTM As Adjunct to...

Related Keywords

Philadelphia , Pennsylvania , United States , Japan , Miami , Florida , American , Mike Moyer , Sunjay Kaushal , National Institute Of Health Heart , Nasdaq , Drug Administration , Blood Institute , Longeveron Inc , Company Quarterly , Longeveron Or Company , National Heart , Exchange Commission , Scientific Sessions Of The American Heart Association , Extended Follow Up Data Show Continued , Transplant Free Survival , Support Continued Investigation , Aging Related Frailty , Scientific Sessions , American Heart Association , Long Term Transplant Free Survival Is Improved , Hypoplastic Left Heart Syndrome , Cell Based Therapy , Chief Science Officer , Single Ventricle Reconstruction , Rare Pediatric Disease Designation , Fast Track Designation , Orphan Drug Designation , Glenn Procedure , National Institute , Englj Med , Private Securities Litigation Reform Act , Quarterly Reports , Nasdaq Lgvn , Longeveron ,